Johnson & Johnson Institute established in Beijing
June 26, 2018 Category China News Round-up, Weekly
U.S. healthcare giant Johnson & Johnson, parent company of Janssen Pharmaceutica, has launched its first Johnson & Johnson Institute with virtual reality technology for the Asia-Pacific region in China, as the company said it sees the country as one of its most important markets. Launched on June 14 in Beijing, the Institute serves as the company’s flagship facility in the Asia-Pacific region. It is one of Johnson & Johnson’s five institutes worldwide equipped with VR technology. With cutting-edge technologies and flexible training designs, the Institute said it aims to raise the national level of professional and systematic development in medical education.
“For a medical technology company, China is the future. We will partner with professional societies and senior healthcare professionals to build education programs for the country’s healthcare professionals, especially young professionals,” said Gavin Fox-Smith, Vice President of Global Education Solutions at Johnson & Johnson Medical Asia-Pacific. “Johnson & Johnson has a very strong commitment to building education programs that supplement medical school training in China, by offering a physical environment, the latest technologies and the best people that are able to facilitate the training,” he said. Tens of millions of dollars have already been invested in the Institute.
“The Institute is estimated to accommodate 60,000 visits annually, while we offer live streaming classes to cover a broader area in China,” said Kevin Chen, Vice President of Operations and Education Solution at Johnson & Johnson Medical (China). The institute in Beijing currently includes three unique VR training modules for orthopedic surgery where doctors can simulate operations with the help of VR technology. With the help of VR, young professionals can acquire skills in a more efficient way, the China Daily reports.
- KURT VANDEPUTTE (UMICORE) APPOINTED CHAIRMAN OF THE BOARD OF THE FLANDERS-CHINA CHAMBER OF COMMERCE (FCCC)
- Webinar: “Knowing Your Chinese Partner” – May 26, 2021, 10 am – 12 am
- EMA starts rolling review of CoronaVac, WHO approves Sinopharm vaccine for emergency use
- The Global Times warns not to politicize the Comprehensive Agreement on Investment (CAI)
- Hainan to become biggest duty-free market in the world